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Abstract
Background: Dropout (DO) is common in the treatment of eating disorders (EDs), but the
reasons for this phenomenon remain unclear. This study is an extensive review of the literature
regarding DO predictors in EDs.
Methods: All papers in PubMed, PsycINFO and Cochrane Library (1980-2009) were considered.
Methodological issues and detailed results were analysed for each paper. After selection according
to inclusion criteria, 26 studies were reviewed.
Results:  The dropout rates ranged from 20.2% to 51% (inpatient) and from 29% to 73%
(outpatient). Predictors of dropout were inconsistent due to methodological flaws and limited
sample sizes. There is no evidence that baseline ED clinical severity, psychiatric comorbidity or
treatment issues affect dropout. The most consistent predictor is the binge-purging subtype of
anorexia nervosa. Good evidence exists that two psychological traits (high maturity fear and
impulsivity) and two personality dimensions (low self-directedness, low cooperativeness) are
related to dropout.
Conclusion:  Implications for clinical practice and areas for further research are discussed.
Particularly, these results highlight the need for a shared definition of dropout in the treatment of
eating disorders for both inpatient and outpatient settings. Moreover, the assessment of personality
dimensions (impulse control, self-efficacy, maturity fear and others) as liability factors for dropout
seems an important issue for creating specific strategies to reduce the dropout phenomenon in
eating disorders.
Background
Eating disorders (EDs) are serious and complex mental
diseases, and their pathogenesis includes individual psy-
chobiological vulnerability (genetic) and shared (culture)
or unshared (life events) environmental factors [1-3].
Treatment of EDs is complex and multidisciplinary [1],
and the rate of dropout is very high: up to 70% of ED
patients drop out of outpatient treatment [4], whereas
reported dropout rates for patients with anorexia nervosa
Published: 9 October 2009
BMC Psychiatry 2009, 9:67 doi:10.1186/1471-244X-9-67
Received: 4 May 2009
Accepted: 9 October 2009
This article is available from: http://www.biomedcentral.com/1471-244X/9/67
© 2009 Fassino et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Psychiatry 2009, 9:67 http://www.biomedcentral.com/1471-244X/9/67
Page 2 of 9
(page number not for citation purposes)
(AN) from specialised inpatient eating disorder pro-
grammes range from 20.2% to 51% [5].
The term "dropout" has been used to describe both the
unilateral ending of regular treatment by a patient and the
decision for administrative discharge made by a treatment
team. Clinicians and researchers working with EDs have
long recognised the problem of treatment dropout and its
implications for long-term recovery [6,7], but for many
years, the dropout phenomenon in EDs was usually
reported only as quantitative data within the context of
clinical trials. Only recently has the relevance of this phe-
nomenon been fully understood [8].
We located reviews of limited interest about this phenom-
enon [9-11]. The review by Mitchell [9] included only
selected trials intended to study the efficacy of treatments.
It is likely that the researchers made several efforts to
reduce the dropout phenomenon in these trials and tried
to include only highly motivated subjects. Therefore, it is
likely that the dropout rate would have been higher in
naturalistic studies. Moreover, predictors of dropout were
seldom analysed in these studies. Mahon's review [10]
focused only on factors leading patients with AN to drop
out, whereas studies of bulimia nervosa (BN) and eating
disorders not otherwise specified (ED-NOS) were
neglected. Bacaltchuk and Hay [11] analysed the dropout
(attrition) rate of bulimic patients from treatment with
SSRIs.
A recent paper by Wallier and colleagues [5] is focused on
dropout from inpatient treatment. The authors revealed
seven studies of interest [6,12-17], and critically discussed
the methodological flaws and the inconsistency of the
results. Although this review is interesting, it is only a par-
tial analysis of the literature. Most individuals with EDs
are treated in an outpatient setting, and hospitalisation
becomes necessary when outpatient programs fail [18]. In
fact, the inpatient population shows more severe overall
eating and psychiatric psychopathology. A comprehensive
review of the dropout phenomenon requires the inclusion
of the outpatient setting.
The study of the features of patients with EDs who do not
complete their treatment program seems to be crucial for
many reasons: (a) the high incidence of this phenomenon
largely decreases the power and generalisability of the
results of clinical trials [8]; (b) most of the non-completer
inpatients affected by EDs have poorer prognoses [15]; (c)
most of the non-completers tend to be referred to special-
ised centres again after months or years, when their psy-
chopathology is more severe and the course of their illness
tends to be chronic [19]; (d) some studies suggest that pre-
mature dropout is a risk factor for relapse within the first
year after hospitalisation [7]; (e) although the estimates
are somewhat inaccurate, dropout appears to be a very
expensive phenomenon in terms of the direct and indirect
costs of chronic EDs [20]; and (f) prediction of dropout is
an important step toward developing interventions to
reduce it and to improve the treatment of engaged and
completer subjects [14,21-23].
Therefore, the aim of this review is to summarise the body
of evidence in this research area, to emphasise its clinical
implications and to highlight some critical points.
Method
Data sources and study selection
The following inclusion criteria were used to select studies
assessing the factors related to early interruption of clini-
cal interventions in subjects with EDs: (a) inclusion in at
least one of three databases, MEDLINE, PsycINFO and
Cochrane Library, from January 1980 to January 2009; (b)
studies with the specific aim of analysing the dropout phe-
nomenon (the trials describing only the number of and
motivations for dropouts were not considered adequate
for inclusion in this review); (c) original articles published
as full papers or brief reports (no letters); (d) inclusion of
at least one form of psychological treatment in addition to
nutritional support and/or medication for inpatient treat-
ment; (e) studies including adult or mixed adolescent/
adult samples - the reasons why younger patients adhere
to treatment could be different from those of older, adult
patients because parental approval is legally required for
treatment or interruption of treatment of minor patients;
and (f) studies published in the English language.
The following medical subject headings or key words were
used: dropout, termination, adherence, attrition, eating
disorders (EDs), bulimia nervosa (BN), anorexia nervosa
(AN). The Cochrane Library and PsycINFO database were
searched with the same key words.
A computerised search and a manual search from the ref-
erences sections of included papers were performed.
The diversity of sample compositions, treatments, defini-
tions of dropouts, settings of treatment and predictors
analysed made it impossible to conduct a meta-analysis of
all of the available studies.
Therefore, this is a descriptive, comprehensive and critical
review of the features of the studies on this topic.
Data extraction
An ad hoc form was designed for data extraction, includ-
ing: (a) authors; (b) therapeutic setting (inpatient or out-
patient) and ED diagnosis; (c) number of subjectsBMC Psychiatry 2009, 9:67 http://www.biomedcentral.com/1471-244X/9/67
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included and dropout rate; (d) two main features of the
samples (age, illness duration); (e) type of treatment; (f)
type of dropout; and (g) predictors of dropout.
All of the studies reviewed are reported in Additional file
1 and Additional file 2.
Dropout definition
The studies reviewed define dropout in different ways. The
terms "dropout", "attrition", and "premature termina-
tion" are often used interchangeably to describe this phe-
nomenon.
Two features appear to characterise the dropout defini-
tion: (a) patient-initiated or staff-initiated discharge or
interruption; and (b) percentage of the treatment program
completed (timing).
Some studies define dropout (type A; DO-A) as a non-
consensual interruption of treatment on the basis of the
patient's decision; several authors define "completers" as
those patients who interrupt treatment after completing
75% of the program, whereas others consider "dropout"
to be the interruption of treatment at any time during the
program. This type of dropout (DO-A) is often operation-
ally defined as "having attended at least one session for
diagnostic assessment or treatment and discontinuing the
assessment or treatment process on the patient's own ini-
tiative by failing to attend any further planned visit"[24].
Other studies (inpatient setting) define dropout in a dif-
ferent way (type B; DO-B): the patients are discharged if
they do not reach the purposed aims at intake (BMI > 19
or interruption of purging behaviours) because not reach-
ing the expected goals is considered by the authors as an
opposition to treatment comparable to dropout [5]. In
this case, the interruption is a staff-initiated dropout.
We included in this review both of these types of dropout
(DO-A; DO-B). Moreover, some researchers (Additional
files 1 and 2) distinguish early dropouts (E-DO) and late
dropouts (L-DO). "Early dropout" refers to an interrup-
tion of treatment after 2-3 sessions or within the first
month; "late dropout" refers to the interruption of treat-
ment after more than one month.
Other authors (inpatient setting) consider "early drop-
outs" to be subjects discharged at or below 80% of IBW
(Ideal Body Weight) and "late dropouts" those discharged
at or above 81% of IBW [5,15].
The inability to initiate the treatment and the refusal of
treatment suggested at intake are defined as "failure to
engage" (FE), but only two studies considered this phe-
nomenon [25,26].
Papers of some interest excluded from the review
One paper was excluded because the authors did not
report a clear definition of dropout [27]. These researchers
showed that the dropouts from an outpatient cognitive
behavioural treatment programme were characterised by
more severe bulimic cognitions and greater impulsivity,
but it was not possible to identify clinically useful predic-
tors.
Four additional papers were excluded because they
included only adolescent subjects younger than 18 years
[16,23,28,29].
One paper was excluded because it is not a study of the
predictors of dropout [30], but an analysis of what hap-
pened to ED subjects who had dropped out of therapy 2-
5 years earlier. The investigators found an unexpected
result: 71% of these subjects were "improved", and no
deaths were recorded. Particularly, subjects with shorter
illness durations and without follow-up treatment were
more likely to be in this improved group.
One paper was excluded because of limitations in the
sample size (only eight subjects) and because only quali-
tative analysis was carried out [31].
Finally, four papers were excluded because of considera-
ble methodological limitations [32-34] concerning data
analysis, sample selection or study design.
Results
Search results
The full text of 52 articles retrieved from PubMed, Psy-
cINFO and Cochrane Library searches was screened. Only
37 papers out of these 52 were considered pertinent, and
26 of these were retained on the basis of the inclusion cri-
teria (eleven were excluded, as described in the preceding
section). The main characteristics of the 26 studies are
listed in Additional files 1 and 2.
Only three papers studying the dropout phenomenon
used a randomised controlled trial (RCT) methodology
[8,35,36], while the others were retrospective and non-
controlled studies.
The dropout rates were 20.2-51% for inpatient treatment
(Additional file 1) and 29-73% for outpatient treatment
(Additional file 2).
Sample composition
The numbers of subjects included in the studies varied
widely (Additional files 1 and 2), ranging from 20 to 261
(mean 110.2; SD = 57.4). Some studies also included
males, but they always represented a negligible portion of
the sample (0-2%), making a comparison based on gen-BMC Psychiatry 2009, 9:67 http://www.biomedcentral.com/1471-244X/9/67
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der impossible. The size of the sample and the diagnosis/
gender composition depend on the characteristics of the
setting (inpatient, outpatient) and on the duration of
observation, whereas the power of the study is not consid-
ered in the majority of these studies.
Differentiating by setting, the mean number of subjects
included in inpatient studies was 143.5 (SD = 44.6), with
a range between 77 [17] and 213 [12], and in outpatient
studies the mean was 92.5 (SD = 56.5), with a range
between 20 [22] and 261 [37].
The mean age of patients included was 24.7 years (SD =
7.4 years) for the nine inpatient studies and 23.9 years
(SD = 6.1 years) for the fifteen outpatient studies (in two
studies, this datum was not mentioned). The mean illness
duration was 6.4 years (SD = 6.1 years) for the nine inpa-
tient studies and 5.5 years (SD = 3.5 years) for the seven
outpatient studies that mentioned this datum. Of course,
age and illness duration are higher in subjects included in
inpatient studies because subjects who need inpatient
treatment are more severely affected by the disorder and
often are more resistant to treatment. Moreover, some of
these studies included mixed samples of patients at first
admission and those who needed more than one hospi-
talisation during the inclusion period [5].
Diagnosis
With regard to DSM-IV or DSM-III (-R) ED diagnoses, six
studies (28.7%) included only subjects with anorexia ner-
vosa (AN), eight (38%) only subjects with bulimia ner-
vosa (BN), and seven (33.3%) both AN and BN subjects
(or ED-Not Otherwise Specified, ED-NOS). In particular,
only five studies included subjects with a diagnosis of ED-
NOS (two inpatient and three outpatient).
Definition and timing of dropout
In terms of the definitions of dropout described above, 19
of the reviewed studies evaluated "type A" dropout (73%),
two "type B" dropout (8%), three both types A and B
(11%), two failure to engage (8%; one only the failure to
engage and one DO-A + FE), and only two discriminated
between "early" and "late" dropout (8%).
Therapeutic setting
Inpatient setting
Nine studies (34.6%) analysed the dropout phenomenon
in an inpatient setting [6,12-15,17,18,37,38]. In one
study, subjects applied to an outpatient setting after dis-
charge from inpatient treatment [35].
Given that female patients with AN need inpatient treat-
ment with greater frequency than subjects with BN, only
two of the studies mentioned above included women
with BN [18,38].
The treatment programs described in these nine studies
are largely equivalent: they all share a nutritional and psy-
chological treatment approach. Medication was also used
in many patients. Most of these studies included family
therapy or counselling for the parents of patients in the
treatment program.
Outpatient setting
Two studies out of the 17 dealing with an outpatient set-
ting included only subjects with AN [8,39], whereas the
others included patients with BN (n = 8) or mixed sam-
ples of subjects with EDs (n = 7). The types of treatment
are highly variable, but, as per the inclusion criteria, all of
these studies involved at least one kind of psychological
treatment (individual or group, cognitive-behavioural or
psychodynamic) in addition to nutritional or medication
treatments. A small subset of these studies had a struc-
tured nutritional approach (7/17).
Predictors
The studies reviewed took very different approaches to
studying the predictors of dropout in the treatment of
subjects with EDs. Some studies aimed to research per-
sonal, clinical and psychological predictors of dropout
with tailored tools, whereas others did not use a standard-
ised and validated assessment, but only retrospective chart
review and clinical records.
Additional files 1 and 2 show all of the predictors found
in the studies included in this review as well as all of the
questionnaires used to research the predictors of dropout.
Almost all of the studies used ED-related inventories.
Only two studies accurately investigated Axis I and II
comorbidity with the SCID-I and II [8,13].
Several of the studied predictors were found to affect
dropout rate, but not all of the variables were studied by
all of the authors. Therefore, a small number of baseline
characteristics were found to predict dropout in two or
more independent studies. In the following, we list all of
the variables that were found in at least one study to be
related to a higher risk of dropout:
ED Diagnosis
The binge-purging subtype of AN was found to predict
dropout in four independent inpatient studies (4/6),
whereas BN predicted dropout in two outpatient studies
(2/7). Three inpatient studies and ten outpatient studies
presented only a single diagnostic group.
Psychological traits and personality
Higher harm avoidance (1/3), lower persistence (1/3) of
temperament, lower self-directedness (2/3) and coopera-
tiveness (2/3) of character; low self-esteem (2/9); higher
interpersonal distrust, difficulties relating to others (2/3),BMC Psychiatry 2009, 9:67 http://www.biomedcentral.com/1471-244X/9/67
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maturity fear (4/15), borderline personality disorder (2/
2), and broadly defined borderline traits (5/15); patient's
higher expectations about treatment (2/2).
Eating symptoms or attitudes
Higher drive for thinness (2/22), higher bulimic attitudes
(2/22), higher body dissatisfaction (2/22), higher perfec-
tionism (1/22), longer illness duration (1/22).
Nutritional status and eating disorder history
Higher body mass index (BMI) at intake (1/19), lower
BMI at intake (1/19), later age of onset (1/19).
Demographic characteristics
Lower age at intake (1/22), older age at intake (1/22),
lower educational level (1/16), employment status (2/
10).
Psychopathological status
Higher depression (1/14), lower depression (1/14),
higher hostility (1/5), impulsivity (2/11) and dissociation
(1/1); poorer anger management (2/2), higher number of
previous psychiatric treatments (2/6).
Life events
Higher rate of early life events, such as sexual abuse (3/3)
or other life events (1/2).
Family environment
Higher expressed emotion (1/4) and level of psychopa-
thology in parents (1/2).
Type of treatment
Only five studies compared more than one treatment and
included this variable in the analysis of the possible pre-
dictors of dropout. In one study, family therapy was more
likely to lead to dropout in BN subjects [35].
Discussion
This review of the literature concerning the dropout phe-
nomenon in eating disorders revealed two major findings:
1) the problem of dropout in treatment of EDs is con-
firmed as a major topic since it occurs in 20-51% of inpa-
tients and 29-73% of outpatients; 2) the number of
predictors found as significant in more than two studies is
very small (AN binge eating/purging type, maturity fear,
broadly defined borderline traits and early life events).
Some interesting results emerged concerning the assess-
ment of these traits within a psychobiological model of
personality (TCI).
Rates of dropout may be influenced by numerous meth-
odological issues. In fact, the available literature is biased
by small samples with different compositions, poor statis-
tical power and a substantial lack of agreement about the
definition of dropout. Particular difficulties emerged in
the interpretation of dropout in inpatient studies because
the administrative staff initiated discharge and termina-
tion decisions by the patient were not always explicitly
mentioned. Moreover, the criteria for administrative dis-
charge vary between the inpatient studies in relation to
clinical practice [5].
Regarding the lack of consistent predictors of dropout, the
small sample sizes in relation to the large number of vari-
ables investigated and the tendency to study only the var-
iables identified in previous studies or only new and
specific psychological and personality dimensions are the
major factors making a quantitative analysis difficult. For
example, only the severity of the eating disorder and
socio-demographic features were studied by all of the
researchers. Both of these types of predictors showed
inconsistent results both in inpatient and outpatient stud-
ies.
The factor most frequently examined and identified as a
predictor of dropout was the AN binge-purging subtype in
inpatient studies [5]. AN-BP subjects may be more impul-
sive and more unstable [40]. It is thus possible that rigid
inpatient treatments requiring early behavioural changes
are not well suited for these patients without a previous
motivational intervention [41,42]. Moreover, the AN-BP
subtype is a well-defined predictor of worse outcome for
anorexia nervosa [43], and these patients have higher
mortality rates.
Of the seven outpatient studies that considered more than
one diagnostic group (AN, BN, ED-NOS), bulimic sub-
jects were identified as more likely to drop out in two
independent studies [4,35]. Therefore, as this predictor is
somewhat consistent with the previous one (anorexia
binge-purging subtype/AN-BP in inpatient studies), it
seems that subjects with impulsive behaviours have a
higher risk of not completing their treatment.
Two related psychological traits emerged as predictors of
dropout in at least two studies (outpatient): 1) Maturity
fear, which expresses the fear of abandoning the confi-
dence of preadolescence and facing the responsibilities of
adulthood [44], and 2) impulsivity.
It is important to underscore that higher levels of impul-
sivity and maturity fear are typical of patients with low
self-esteem and "borderline" features [44]. Borderline per-
sonality disorder or "borderline traits" have been identi-
fied as predictors of dropout in EDs in at least seven
studies included in this review [12-14,25,26,39,45] and
also in personality disorder treatment [46]. These subjectsBMC Psychiatry 2009, 9:67 http://www.biomedcentral.com/1471-244X/9/67
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have difficulties with the regulation of self-esteem and
affect in addition to problems with separating and with
impulse control [47].
Personality functioning was considered in different ways
by 46% (12/26) of the authors, and most of these authors
showed that some personality traits, dimensions or pat-
terns of functioning play an important role in dropout.
Numerous previous studies have demonstrated with the
Temperament and Character Inventory (TCI) [48] that
harm avoidance, novelty seeking and self-directedness
may have a pathogenetic role in EDs [49]. Moreover, a
high level of harm avoidance (HA) seems to be an endo-
phenotype related to vulnerability to the development of
EDs [50]. The self-directedness (SD) scale of the TCI,
which describes the ability of the individual to define and
pursue goals and to have mature and balanced relation-
ships [48], is related to the severity of BN [51], to anger
management in ED [40], and to the response to psycho-
logical treatment [52].
Only three studies in outpatients and in inpatients
[18,39,45] investigated the personality dimensions of
temperament and character (assessed with the TCI- Tem-
perament and Character Inventory) as predictors of drop-
out: Fassino and coworkers identified a dimension of
temperament (higher harm avoidance in AN) and two of
character (lower self-directedness and cooperativeness in
AN and BN) as predictors of dropout in outpatients with
EDs, whereas Dalle Grave and colleagues [18] found a
relation between dropout and a lower persistence of tem-
perament in inpatients.
Axis II personality disorders (PD) received little attention.
Researchers failed to find any consistent association
between PD and dropout, in contrast with the evidence
that the presence of Axis II comorbidity leads to difficul-
ties in the psychotherapeutic relationship [41] in EDs.
The results regarding mood state are controversial in both
inpatient and outpatient studies. Overall, general psycho-
pathology seems to play a negligible role in the early inter-
ruption of treatment in EDs, whereas two studies showed
that the number of previous hospitalisations and psychi-
atric treatments predicted dropout [13,53]. These two var-
iables can decrease the motivation to finish treatments,
particularly in residential programs.
Another variable identified in two studies was difficulties
with anger management [39,45]. Recently, investigators
have paid greater attention to anger and aggressiveness
management in EDs [54]. Anger management seems to
play a pathogenetic role in both AN and BN [40]. Similar
data illustrate the role of hostility in dropping out [55].
Further studies in this field are required.
As to the type of treatment, only one study showed that
family therapy is more likely to lead to an early interrup-
tion of treatment in BN subjects [35]. Other studies
[6,8,24] did not support this result. Further investigations
in this area are needed because the settings and programs
of treatment are very different in the studies reviewed both
for inpatient [5] and outpatient treatment: eclectic vs.
non-eclectic, integrated vs. not integrated, psychological
vs. combined treatment (nutritional and psychological),
combined vs. sequential treatment [6].
This topic is of extreme interest because it is conceivable
that administration of treatments in sequential order [56]
may allow clinicians to address issues that may hinder
adequate collaboration with treatment. This as yet
untested approach may also lead to individualised strate-
gies based on the fact that a treatment that is helpful to
many patients may not be suitable or may even be harm-
ful in a specific subgroup [57].
The inadequacies of standard clinical assessment in psy-
chiatry have been recently outlined [58]. The staging
method, whereby a disorder is characterised according to
its seriousness, extension and features, has achieved wide-
spread currency in medicine, but it is currently neglected
in psychiatry [58,59]. Staging has the potential for
improving the logic and timing of interventions, just as it
does in many complex and serious medical disorders.
Prochaska [60] developed a staging system for readiness
to change (precontemplation, contemplation, prepara-
tion, action, maintenance, termination) that may find
applicability in EDs [61]. The sequential model may again
be appropriate for improving readiness to change before
treatment of EDs, thus potentially yielding a lower rate of
dropout. There have been only a few attempts to evaluate
this treatment strategy, and data about the role of stage of
change in the dropout phenomenon are still preliminary
[62]. Moreover, a poor motivation for and/or dissatisfac-
tion with the treatment are usually found in patients with
psychiatric disorders who drop out of cognitive behav-
ioural therapy [63].
It is also important to understand whether dropout is
always a negative event for patients and their families, and
follow-up studies in this area are needed. Resistance to
treatment does not necessarily mean resistance to change
[6]. Moreover, it is useful to remember that "showing up
for treatment does not necessarily mean compliance with
treatment or following treatment recommendations" [8].
In fact, preliminary results indicate that several dropout
subjects are improved at follow-up [30]. These data seemBMC Psychiatry 2009, 9:67 http://www.biomedcentral.com/1471-244X/9/67
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to highlight the difficulties of defining effective psycho-
therapy treatments [64-67].
Conclusion
In conclusion, the fact that patients with EDs who do not
accept or complete treatment are often more improved at
follow-up than completers indicates that this should be a
primary area for research on EDs.
Currently, though the results are still preliminary, a
patient with a high risk profile for dropout is characterised
by a diagnosis of binge-purging anorexia (inpatient set-
ting) or a more severe bulimic symptomatology (outpa-
tient setting) and tends to have borderline personality
traits or a low ability to pursue his or her life's goals (low
self-directedness).
These subjects with higher dropout risk seem to corre-
spond to the subgroup of ED patients defined as "impul-
sive" [68] or "emotionally dysregulated" [69]. This
subgroup of subjects is more frequent in individuals with
diagnoses on the bulimia nervosa spectrum (AN-BP or BN
diagnosis), who seem to have a genetic predisposition to
greater psychiatric and personality comorbidity [70],
poorer response to treatments [71] and a specific vulnera-
bility to early life events [70]. This also seems to explicate
the role of life events in predicting a higher risk of dropout
in BN subjects: only a few researchers [72] have studied
this aspect, but they found that parental breakup and
childhood trauma (particularly sexual abuse) are signifi-
cant predictors of early interruption of outpatient treat-
ment.
In conclusion, the aims of this review were: (a) to create
an incentive to adopt a shared definition of dropout in
future studies, as proposed in the section entitled "Drop-
out definition", for inpatient and outpatient settings; (b)
to motivate a wide-ranging assessment of the phenome-
non of dropout, which should always include socio-
demographic features, severity of the ED, nutritional sta-
tus, dimensional assessment of personality (TCI or other
similar instruments), Axis I and II comorbidity evalua-
tion, eating and general psychopathology assessment with
widely used psychometric scales, family assessment, life
events and patients' perspective registration; (c) to create
an incentive to use a kind of staging method for the assess-
ment of readiness to change or similar issues in clinical
practice; (d) the follow-up of dropouts; (e) the study of
techniques and strategies to reduce the dropout phenom-
enon [23].
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